














Rethinking cancer survivorship: 
the Prostate Cancer 
Survivorship Essentials 
Framework
To the Editor: The broadly accepted 
definition of a cancer survivor recognises 
that the survivorship begins at diagnosis.1 
However, survivorship care pathways 
conventionally begin at completion of 
active treatment, presenting a challenge 
for addressing survivorship needs at 
diagnosis and for people living with 
incurable cancer.2 A revision of the 
concept of cancer survivorship is needed, 
placing the survivor at the centre of 
a dynamic experience of life after a 
cancer diagnosis and opening up the 
survivorship experience to persons at any 
stage of cancer and at any phase of their 
disease trajectory.
Until now, clinical care guidelines and 
models of survivorship have typically 
not included consumer input, but rather 
have been developed principally through 
health professional expert consensus.3,4 
In a novel approach from 2019– 2020, 
a panel of 47 experts and consumers 
across Australia and New Zealand came 
together to define six key domains of 
survivorship care in a Prostate Cancer 
Survivorship Essentials Framework:5 
health promotion and advocacy, shared 
management, vigilance, personal agency, 
care coordination, and evidence- based 
survivorship interventions.
These six domains reached high 
consensus as being essential, with the 
26 elements within domains all rated 
as high importance. Almost one- third 
of the 47- member panel were cancer 
survivors working collaboratively with 
medical, allied health and nursing expert 
representatives. The degree of consensus 
in such a broad coalition is remarkable, 
underscoring the validity of the approach 
that reflects the lived experience driven 
by survivors’ preferences.
Importantly, the central domain related 
to personal agency of a survivor as a 
key element that linked all others (Box) 
and all domains were framed around 
outcomes that mattered for the patient 
(eg, empowerment, information, shared 
decision making, care coordination, 
symptom management). While the 
framework was developed for prostate 
cancer survivorship, none of the 
elements were unique to prostate cancer, 
highlighting the potential relevance of the 
framework to other cancers. More broadly, 
this approach aligns with existing models 
of chronic disease management and 
frameworks of consumer engagement in 
care that are fundamental to the delivery of 
health care in Australia and New Zealand.
We believe the essentials framework is 
applicable to other adult cancer patient 
cohorts and presents an opportunity to 
move forward on cancer survivorship 
in Australia, taking forward a unique 
consumer– practitioner model where the 
survivor is not just the passive object of 
care but an actor in their own health and an 
empowered and supported agent of change.
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